Table 2 Detailed statistics corresponding with Fig. 2
Comparison | Statistical test | n | Statistic | p-value | Outliers? | Figure | |
---|---|---|---|---|---|---|---|
A | CD68 across development: Males | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,61)=4.58 | 0.006 | P20: 1; P30: 1; P54: 1 | Fig. 2b |
P20:P30 | Holm-Sidak's posthoc | 12:17 | t(61)=2.66 | 0.049 | |||
P20:P38 | Holm-Sidak's posthoc | 12:21 | t(61)=2.28 | 0.078 | |||
P20:P54 | Holm-Sidak's posthoc | 12:15 | t(61)=0.08 | 0.936 | |||
P30:P38 | Holm-Sidak's posthoc | 17:21 | t(61)=0.54 | 0.832 | |||
P30:P54 | Holm-Sidak's posthoc | 17:15 | t(61)=2.92 | 0.029 | |||
P38:P54 | Holm-Sidak's posthoc | 21:15 | t(61)=2.54 | 0.054 | |||
B | CD68+ D1r content across development: Males | one-way ANOVA | 4 animals; 2 sections/animal; 1-3zstacks/section | F(3,60)=3.89 | 0.013 | P20: 1; P30: 1; P38: 1; P54: 1 | Fig. 2b |
P20:P30 | Holm-Sidak's posthoc | 12:17 | t(60)=2.54 | 0.066 | |||
P20:P38 | Holm-Sidak's posthoc | 12:20 | t(60)=1.93 | 0.166 | |||
P20:P54 | Holm-Sidak's posthoc | 12:15 | t(60)=0.10 | 0.921 | |||
P30:P38 | Holm-Sidak's posthoc | 17:20 | t(60)=0.77 | 0.689 | |||
P30:P54 | Holm-Sidak's posthoc | 17:15 | t(60)=2.81 | 0.039 | |||
P38:P54 | Holm-Sidak's posthoc | 20:15 | t(60)=2.17 | 0.129 | |||
C | CD68+ C3 content across development: Males | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,61)=1.35 | 0.267 | P30: 1; P38: 1; P54: 1 | Fig. 2c |
D | CD68+ C3-D1r content across development: Males | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,60)=5.70 | 0.002 | P20: 1; P30: 1; P38: 1; P54: 1 | Fig. 2d |
P20:P30 | Holm-Sidak's posthoc | 12:17 | t(60)=2.79 | 0.028 | |||
P20:P38 | Holm-Sidak's posthoc | 12:20 | t(60)=0.09 | 0.933 | |||
P20:P54 | Holm-Sidak's posthoc | 12:15 | t(60)=0.77 | 0.714 | |||
P30:P38 | Holm-Sidak's posthoc | 17:20 | t(60)=3.10 | 0.015 | |||
P30:P54 | Holm-Sidak's posthoc | 17:15 | t(60)=3.81 | 0.002 | |||
P38:P54 | Holm-Sidak's posthoc | 20:15 | t(60)=0.96 | 0.714 | |||
E | CD68 across development: Females | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,41)=7.59 | <0.001 | P20: 1; P38: 1 | Fig. 2e |
P20:P30 | Holm-Sidak's posthoc | 8:12 | t(41)=3.25 | 0.012 | |||
P20:P38 | Holm-Sidak's posthoc | 8:10 | t(41)=0.95 | 0.346 | |||
P20:P54 | Holm-Sidak's posthoc | 8:15 | t(41)=1.35 | 0.334 | |||
P30:P38 | Holm-Sidak's posthoc | 12:10 | t(41)=4.52 | <0.001 | |||
P30:P54 | Holm-Sidak's posthoc | 12:15 | t(41)=2.30 | 0.078 | |||
P38:P54 | Holm-Sidak's posthoc | 10:15 | t(41)=2.56 | 0.056 | |||
F | CD68+ D1r content across development: Females | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,40)=3.81 | <0.001 | P20: 1; P38: 1 | Fig. 2f |
P20:P30 | Holm-Sidak's posthoc | 8:12 | t(40)=3.13 | 0.016 | |||
P20:P38 | Holm-Sidak's posthoc | 8:10 | t(40)=0.89 | 0.381 | |||
P20:P54 | Holm-Sidak's posthoc | 8:14 | t(40)=1.58 | 0.228 | |||
P30:P38 | Holm-Sidak's posthoc | 12:10 | t(40)=4.32 | <0.001 | |||
P30:P54 | Holm-Sidak's posthoc | 12:14 | t(40)=1.85 | 0.201 | |||
P38:P54 | Holm-Sidak's posthoc | 10:14 | t(40)=2.71 | 0.039 | |||
G | CD68+ C3 content across development: Females | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,32)=9.39 | <0.001 | P30: 1 | Fig. 2g |
P20:P30 | Holm-Sidak's posthoc | 6:8 | t(32)=4.42 | <0.001 | |||
P20:P38 | Holm-Sidak's posthoc | 6:10 | t(32)=4.46 | <0.001 | |||
P20:P54 | Holm-Sidak's posthoc | 6:12 | t(32)=2.19 | 0.071 | |||
P30:P38 | Holm-Sidak's posthoc | 8:10 | t(32)=0.17 | 0.864 | |||
P30:P54 | Holm-Sidak's posthoc | 8:12 | t(32)=2.83 | 0.032 | |||
P38:P54 | Holm-Sidak's posthoc | 10:12 | t(32)=2.83 | 0.032 | |||
H | CD68+ C3-D1r content across development: Females | one-way ANOVA | 4 animals; 2 sections/animal; 1-3 zstacks/section | F(3,38)=0.11 | 0.160 | P30: 1; P38: 1 | Fig. 2h |